ATE211473T1 - Äthylenglykolester von monohydrobenzoporphyrinderivaten als photoaktive mittel - Google Patents

Äthylenglykolester von monohydrobenzoporphyrinderivaten als photoaktive mittel

Info

Publication number
ATE211473T1
ATE211473T1 AT98921294T AT98921294T ATE211473T1 AT E211473 T1 ATE211473 T1 AT E211473T1 AT 98921294 T AT98921294 T AT 98921294T AT 98921294 T AT98921294 T AT 98921294T AT E211473 T1 ATE211473 T1 AT E211473T1
Authority
AT
Austria
Prior art keywords
monohydrobenzoporphyrine
derivatives
ethylene glycol
glycol ester
photoactive agents
Prior art date
Application number
AT98921294T
Other languages
English (en)
Inventor
Ethan Sternberg
David Dolphin
Julia G Levy
Anna M Richter
David W C Hunt
Ashok Jain
Elizabeth M Waterfield
Original Assignee
Quadra Logic Tech Inc
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc, Univ British Columbia filed Critical Quadra Logic Tech Inc
Application granted granted Critical
Publication of ATE211473T1 publication Critical patent/ATE211473T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
AT98921294T 1997-05-07 1998-05-06 Äthylenglykolester von monohydrobenzoporphyrinderivaten als photoaktive mittel ATE211473T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85249497A 1997-05-07 1997-05-07
PCT/CA1998/000468 WO1998050387A1 (en) 1997-05-07 1998-05-06 Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents

Publications (1)

Publication Number Publication Date
ATE211473T1 true ATE211473T1 (de) 2002-01-15

Family

ID=25313492

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98921294T ATE211473T1 (de) 1997-05-07 1998-05-06 Äthylenglykolester von monohydrobenzoporphyrinderivaten als photoaktive mittel

Country Status (21)

Country Link
US (2) US5929105A (de)
EP (2) EP0983273B8 (de)
JP (1) JP3378889B2 (de)
KR (1) KR100397131B1 (de)
CN (1) CN1113882C (de)
AR (1) AR012673A1 (de)
AT (1) ATE211473T1 (de)
AU (1) AU741070B2 (de)
CA (1) CA2284879C (de)
CZ (1) CZ294715B6 (de)
DE (1) DE69803376T2 (de)
DK (1) DK0983273T3 (de)
ES (2) ES2437790T3 (de)
HK (1) HK1042439B (de)
HU (1) HU221754B1 (de)
IL (1) IL132066A (de)
NO (1) NO314264B1 (de)
NZ (1) NZ338031A (de)
PL (1) PL202341B1 (de)
PT (1) PT983273E (de)
WO (1) WO1998050387A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756396B1 (en) * 1997-05-07 2004-06-29 Qlt Inc. Ethylene glycol esters as photoactive agents
US6364907B1 (en) 1998-10-09 2002-04-02 Qlt Inc. Method to prevent xenograft transplant rejection
US6331235B1 (en) * 1998-12-11 2001-12-18 The University Of British Columbia Chiral separation of benzoporphyrin derivative mono-and di-acids by laser-induced fluorescence capillary electrophoresis
US6344050B1 (en) 1998-12-21 2002-02-05 Light Sciences Corporation Use of pegylated photosensitizer conjugated with an antibody for treating abnormal tissue
EP1131099A2 (de) * 1999-01-15 2001-09-12 Light Sciences Corporation Nichtinvasiven vaskulären therapie
US6602274B1 (en) * 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
AU2789900A (en) * 1999-02-26 2000-09-21 Qlt Phototherapeutics, Inc. Photodynamic therapy in combination with apoptosis inducing factors
GB9905911D0 (en) 1999-03-15 1999-05-05 Photocure As Method
US6609014B1 (en) 1999-04-14 2003-08-19 Qlt Inc. Use of PDT to inhibit intimal hyperplasia
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
US7122568B1 (en) 1999-11-17 2006-10-17 Qlt, Inc. Use of low-dose PDT to inhibit restenosis
US20040208855A1 (en) * 1999-11-17 2004-10-21 Allison Beth Anne Use of PDT to inhibit intimal hyperplasia
WO2001051087A2 (en) * 2000-01-12 2001-07-19 Light Sciences Corporation Novel treatment for eye disease
AU2001258117A1 (en) 2000-05-08 2001-11-20 The University Of British Columbia Supports for photosensitizer formulations
WO2001085212A2 (en) * 2000-05-08 2001-11-15 The University Of British Columbia Drug delivery systems for photodynamic therapy
US7521239B2 (en) * 2000-11-29 2009-04-21 Pci Biotech As Photochemical internalization for virus-mediated molecule delivery into the cyosol
BR0115795A (pt) * 2000-11-29 2003-08-12 Pci Biotech As Métodos para introduzir uma molécula no citosol de uma célula, para o tratamento ou prevenção de uma doença, distúrbio ou infecção em um paciente, para estimular uma resposta imune, célula, e, uso de uma molécula de transferência e/ou um agente fotossensibilizante
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
CA2448562A1 (en) * 2001-05-31 2002-12-05 Miravant Pharmaceuticals, Inc. Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
EP1424942B1 (de) * 2001-08-22 2008-12-31 Montana State University-Bozeman Porphyrine mit verbesserten multi-photonen-absorptionsquerschnitten für die photodynamische therapie
US20040013717A1 (en) * 2001-11-02 2004-01-22 Allen Theresa Mary PEG-lipid containing formulations
DE60225169D1 (de) 2001-11-09 2008-04-03 Quadra Logic Tech Inc Photodynamische therapie zur behandlung von haarausfall
US7264629B2 (en) 2001-11-09 2007-09-04 Qlt, Inc. Photodynamic therapy for the treatment of hair loss
CA2437638A1 (en) * 2003-08-20 2005-02-20 John Robert North Photodynamic therapy
CA2457214A1 (en) 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne
US20120034155A1 (en) * 2010-08-03 2012-02-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Artificial cells
CN102482249B (zh) 2009-07-08 2016-06-08 德米拉(加拿大)公司 用于治疗皮肤病症或疾病状态的tofa类似物
WO2011097533A1 (en) 2010-02-04 2011-08-11 Transmolecular, Inc. Chlorotoxin polypeptides and conjugates and uses thereof
JP5964322B2 (ja) 2011-01-13 2016-08-03 キュー エル ティー インク．ＱＬＴ Ｉｎｃ． 光増感剤の局所送達用医薬組成物及びその使用
WO2013003507A1 (en) 2011-06-27 2013-01-03 Morphotek, Inc. Multifunctional agents
JP6181059B2 (ja) 2011-10-25 2017-08-16 メモリアル スローン−ケタリング キャンサー センター 前立腺がんのための診断薬、予後判定薬、および治療薬としてのフリーｐｓａ抗体
KR20150030763A (ko) 2012-07-11 2015-03-20 더미라, 인코포레이티드 감광제의 국부 전달을 위한 약제학적 조성물 및 이의 이용
US9365542B2 (en) 2012-10-26 2016-06-14 Memorial Sloan-Kettering Cancer Center Modulators of resistant androgen receptor
EP3087182B1 (de) 2013-12-23 2019-03-20 Memorial Sloan-Kettering Cancer Center Verfahren und zusammensetzungen zur behandlung von krebs unter verwendung von peptidnukleinsäurebasiertem wirkstoff

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883790A (en) 1987-01-20 1989-11-28 University Of British Columbia Wavelength-specific cytotoxic agents
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
US5095030A (en) * 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
US5171749A (en) 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
EP0476011A1 (de) * 1989-06-07 1992-03-25 The University Of British Columbia Mittels diels-alder-reaktion hergestellte fotosensibilisatorische porphyrinderivate
US5498710A (en) * 1994-04-22 1996-03-12 Health Research, Inc. Alkyl ether analogues of benzoporphyrin derivatives
ATE253068T1 (de) * 1997-05-07 2003-11-15 Univ British Columbia Ein klasse von benzoporphyrin derivate photowirksame verbindungen

Also Published As

Publication number Publication date
HUP0003604A2 (hu) 2001-02-28
PT983273E (pt) 2002-06-28
AU7420798A (en) 1998-11-27
NO995436D0 (no) 1999-11-05
HU221754B1 (hu) 2002-12-28
US5929105A (en) 1999-07-27
EP0983273B1 (de) 2002-01-02
AU741070B2 (en) 2001-11-22
NO314264B1 (no) 2003-02-24
EP1177795A2 (de) 2002-02-06
CZ294715B6 (cs) 2005-02-16
EP0983273B8 (de) 2002-10-09
CN1254339A (zh) 2000-05-24
KR20010012331A (ko) 2001-02-15
HUP0003604A3 (en) 2002-04-29
NO995436L (no) 2000-01-04
US6153639A (en) 2000-11-28
CA2284879C (en) 2005-10-25
HK1042439B (zh) 2014-02-28
ES2171022T3 (es) 2002-08-16
DE69803376D1 (de) 2002-02-28
NZ338031A (en) 2001-04-27
EP1177795B1 (de) 2013-09-11
CA2284879A1 (en) 1998-11-12
EP0983273A1 (de) 2000-03-08
ES2437790T3 (es) 2014-01-14
CZ392399A3 (cs) 2000-02-16
WO1998050387A1 (en) 1998-11-12
CN1113882C (zh) 2003-07-09
IL132066A0 (en) 2001-03-19
IL132066A (en) 2008-06-05
JP3378889B2 (ja) 2003-02-17
PL336790A1 (en) 2000-07-17
AR012673A1 (es) 2000-11-08
KR100397131B1 (ko) 2003-09-13
PL202341B1 (pl) 2009-06-30
DE69803376T2 (de) 2002-08-14
JP2001507369A (ja) 2001-06-05
DK0983273T3 (da) 2002-04-22
EP1177795A3 (de) 2002-05-29

Similar Documents

Publication Publication Date Title
ATE211473T1 (de) Äthylenglykolester von monohydrobenzoporphyrinderivaten als photoaktive mittel
NL300304I2 (nl) Pleuromutilinderivaten als antibacteriele middelen
ATE219485T1 (de) N-benzyl-2-phenylindole als östrogene mittel
NO2011015I2 (no) Paliperidon palmitatester
DE69930518D1 (de) Als antikrebsmittel verwendbare alkinyl-substituierte chinolin-2-on-derivate
FI973680A0 (fi) Foerfarande och anordning vid blodtrycksmaetning
DE69725465D1 (de) 6-phenylpyridyl-2-amin-derivate verwendbar als nos-inhibitoren
DE60038268D1 (de) Kosmetische Zubereitungen
ATE219490T1 (de) Indazoleamid-verbindungen als serotoninergene mittel
DE59804418D1 (de) Kosmetische zubereitungen
DE69728139T2 (de) Pyrrolopyrrolone als inhibitoren von neutrophiler elastase
DE59813430D1 (de) Perylenhydrazidimide als Carbonylderivatisierungsreagenzien
ATE226203T1 (de) Azabicycliache carbamoyloxy mutilin derivate als antibakterielles mittel
DE69925882D1 (de) Aminosäurederivate als Entzündungshemmende Mittel
FI973690A0 (fi) Foerfarande och arrangemang vid en kombikraftanlaeggning
FI973377A0 (fi) Foerfarande och anordning vid torkning av en cellulosabana
ATE204255T1 (de) Carbostyrilderivate als antithrombotische mittel
ATE221065T1 (de) Amidinderivate als inhibitoren von no-synthase
ATE236150T1 (de) (4-piperidinyl)-1h-2-benzopyran derivate verwendbar als antipsychotische mittel
EE200000239A (et) Uued metüleenbisfosfoonhappe derivaadid
DE59506998D1 (de) Kosmetische mittel
DE69612049D1 (de) Campherderivate als Duftmittel
FI972228A0 (fi) Foerfarande och anordning vid spetsdragning av pappersbana
DE69809891D1 (de) Nitro-benzamid verwendbar als antiarrythmica
DE60006698D1 (de) Unsubstituierte ethyl- und propylderivate von phenoxythienoisoxazolen als d4 antagonisten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification